tianda holdings ltd (455) Snapshot

The board of directors of Tianda Pharmaceuticals Limited announced that the registered office address of the company in the Cayman Islands has been changed to Cricket Square, Hutchins Drive, P.O. Box 2681, Grand Cayman KY1-1111, Cayman Islands with effect from 17th December, 2012.

Tianda Pharmaceuticals Limited has ample cash of around $40 billion and it will consider acquisition opportunities. Wu Wing Keung, Head Of Investment Development in Tianda, said the acquisition targets are mainly profitable drug makers in China whose products are well-received in market and also did not rule out the possibility of seeking for overseas partners.

Tianda Pharmaceuticals Limited reported unaudited consolidated earnings results for the six months ended September 30, 2012. For the period, the company reported revenue of HKD 67,307,603 against HKD 51,643,979 a year ago. Profit before tax was HKD 29,950,453 against HKD 32,810,289 a year ago. Profit for the period from continuing operations was HKD 25,284,326 against HKD 25,978,626 a year ago. Profit for the period was HKD 42,221,086 against HKD 44,455,182 a year ago. Profit for the period attributable to the owners of the company from continuing operations was HKD 11,193,445 or HKD 0.60 per basic share against HKD 12,640,996 or HKD 0.68 per basic share a year ago. The significant increase in revenue was mainly attributable to the inclusion of sales of Tianda Pharmaceuticals Group from September 01, 2012 onward, which contributed approximately HKD 9.4 million for in first half of fiscal year 2013, upon completion of the business restructuring.